KIMBERLY MULLINS: Open Payments
NPI 1235152851 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 24 payments from 15 companies in 2025. Trend: 2023 $45 · 2024 $111 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| ABBVIE INC. | 2 | $62 |
| Merck Sharp & Dohme LLC | 2 | $60 |
| Astellas Pharma US Inc | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| TerSera Therapeutics LLC | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: KEYTRUDA, IMFINZI, KISQALI, EPKINLY, FRUZAQLA, Tecentriq Hybreza, IMBRUVICA, OJJAARA.
Industry payments across OH — which companies pay providers there.
